Assenagon Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-17,017
| Closed | -$1.82M | – | 1373 |
|
|
2024
Q2 | $1.82M | Sell |
17,017
-1,534
| -8% | -$164K | ﹤0.01% | 916 |
|
|
2024
Q1 | $2.23M | Sell |
18,551
-98
| -0.5% | -$11.8K | 0.01% | 832 |
|
|
2023
Q4 | $2.29M | Sell |
18,649
-194
| -1% | -$23.9K | 0.01% | 841 |
|
|
2023
Q3 | $2.44M | Sell |
18,843
-432
| -2% | -$55.9K | 0.01% | 764 |
|
|
2023
Q2 | $2.39M | Sell |
19,275
-9,923
| -34% | -$1.23M | 0.01% | 690 |
|
|
2023
Q1 | $4.27M | Buy |
29,198
+26,962
| +1,206% | +$3.95M | 0.02% | 591 |
|
|
2022
Q4 | $356K | Sell |
2,236
-3,737
| -63% | -$595K | ﹤0.01% | 1163 |
|
|
2022
Q3 | $796K | Sell |
5,973
-40,487
| -87% | -$5.4M | ﹤0.01% | 957 |
|
|
2022
Q2 | $7.25M | Buy |
46,460
+41,794
| +896% | +$6.52M | 0.03% | 435 |
|
|
2022
Q1 | $726K | Sell |
4,666
-137,936
| -97% | -$21.5M | ﹤0.01% | 1085 |
|
|
2021
Q4 | $18.2M | Buy |
142,602
+139,073
| +3,941% | +$17.7M | 0.05% | 194 |
|
|
2021
Q3 | $460K | Sell |
3,529
-51,431
| -94% | -$6.7M | ﹤0.01% | 1039 |
|
|
2021
Q2 | $9.76M | Buy |
54,960
+23,717
| +76% | +$4.21M | 0.03% | 314 |
|
|
2021
Q1 | $5.14M | Buy |
+31,243
| New | +$5.14M | 0.02% | 470 |
|
|
2020
Q3 | – | Sell |
-8,962
| Closed | -$989K | – | 1197 |
|
|
2020
Q2 | $989K | Sell |
8,962
-19,308
| -68% | -$2.13M | 0.01% | 766 |
|
|
2020
Q1 | $2.82M | Sell |
28,270
-147,551
| -84% | -$14.7M | 0.02% | 269 |
|
|
2019
Q4 | $26.2M | Buy |
175,821
+150,122
| +584% | +$22.4M | 0.17% | 74 |
|
|
2019
Q3 | $3.29M | Sell |
25,699
-150,967
| -85% | -$19.3M | 0.02% | 272 |
|
|
2019
Q2 | $25.2M | Buy |
176,666
+165,249
| +1,447% | +$23.6M | 0.19% | 69 |
|
|
2019
Q1 | $1.63M | Buy |
+11,417
| New | +$1.63M | 0.02% | 535 |
|
|
2018
Q1 | – | Sell |
-4,210
| Closed | -$567K | – | 596 |
|
|
2017
Q4 | $567K | Buy |
+4,210
| New | +$567K | 0.01% | 532 |
|